🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A group led by Julia Lang reports in @nature that, across almost all scientific fields & career stages, that women scientists are less likely to be credited for their scientific contributions than male scientists. OA: rdcu.be/cQiY8 nature.com/articles/s4158…

Today I signed an Executive Order to protect the reproductive rights of women in the aftermath of the Supreme Court's extreme decision to overturn Roe v. Wade. It formalizes the actions I announced right after the decision and will add new measures to protect women's health.

Do natural killer cells and complement modulation have a potential role against pancreatic cancer? Check out our collaborative effort from the Giaccia lab and Quynh Thu Le lab at Stanford Radiation Oncology. aacrjournals.org/cancerrescommu…

Very excited to share our new paper, now out in Science Translational Medicine! science.org/doi/10.1126/sc… (1/3)

Excited to share our #preprint on a novel drug-like molecule which engages DAF-12/FXR to induce mitophagy & promote mitochondrial mediated lifespan⬆️.Thanks to all the authors! Julie K Andersen Malene Hansen Lab Caroline Kumsta Dhanya Nambiar Angeli Lab Buck Institute researchsquare.com/article/rs-184…

Congratulations to Dr. Quynh-Thu Le and Dr. Max Diehn for receiving funding for their Program Project Grant, “Molecular Strategies to Widen the Therapeutic Index of Radiotherapy.”

Just in! First selfie from our 2022 #NobelPrize laureate in chemistry Carolyn Bertozzi. Congratulations!

Very excited to share our latest collaborative study with the great #JennyTing showing that B cells can provide resistance to systemic STING agonist therapy, a superstar effort by Sirui Li and #RahulMirlekar UNC Lineberger UNC Pancreas Center 👇nature.com/articles/s4158…

IT'S OUT:Our paper on elective nodal irradiation mitigates local and systemic immunity generated by combination radiation + immunotherapy in head and neck tumors. Link: nam02.safelinks.protection.outlook.com/?url=https%3A%…

FINALLY, OUT: Our Trial Results with Neoadjuvant Durvalumab + SBRT in locally advanced HPV unrelated HNSCC. doi.org/10.1038/s43018… or nature.com/articles/s4301….

Holiday lunch with our basic and clinic research team

About 10% of patients experience hyper-progression after immunotherapy. This very cool paper shows that it is the beloved CD8+ T cells that drive cancer hyperprogression via IFNγ! This alters B-catenin signaling. Great work! cell.com/cancer-cell/fu…

Precision radiation medicine coming to #HNCSM🚗😊 📢Mutant NRF2 confers head & neck cancer radioresistance which can be overcome by @NCICTEP_ClinRes glutaminase inhibitor Cool study Quynh Thu Le Max Diehn, MD/PhD Stanford Radiation Oncology #radonc #radbio🙏 OncoAlert aacrjournals.org/cancerres/arti…

I'm thrilled and delighted to be a part of this multi-collaborative research endeavor. Congratulations Vijay and all the authors involved! science.org/doi/epdf/10.11…

Could taurine be an anti-aging intervention in humans? Landmark study Science Magazine shows restoring “youthful” levels of taurine hit several hallmarks of aging in worms, mice and monkeys. Buck researchers were involved in the work and talk about here: buckinstitute.org/blog/taurine-s…

Very excited to share the latest preprint from the Lithgow Lab Buck Institute linking protein insolubility with Alzheimer's and the diseases of aging! biorxiv.org/content/10.110… A thread of the story (1/11)

Read the article in the latest issue— Galectin-1 Mediates Chronic STING Activation in Tumors to Promote #Metastasis through MDSC Recruitment, by Dhanya Nambiar, Quynh Thu Le et al. bit.ly/3F6J8lm Stanford Medicine

Excited to share our latest research: MIC, a benzocoumarin molecule that enhances #longevity in #celegans by triggering #mitophagy. Our findings also show MIC's effectiveness in mammalian cells, indicating potential broader application. Full text here: rdcu.be/dqZmE

Check out the latest Olcina_Lab publication - we describe a way to improve radiotherapy in tumours with immunosuppressive microenvironments  Many thanks to everyone who made this possible! jci.org/articles/view/… Medical Research Council Cancer Research UK Academy of Medical Sciences NIH Oxford Cancer OxfordOncology